RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Washington D.C., DC · +41 more sites
Multiple Sclerosis clinical trials in Washington D.C., DC
8 recruiting multiple sclerosis studies with a site in Washington D.C., DC.
All trials in Washington D.C., DC · All Multiple Sclerosis trials
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Washington D.C., DC · +50 more sites
RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Washington D.C., DC · +108 more sites
RecruitingPhase 3NCT05877963
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Sponsor: TG Therapeutics, Inc.
Washington D.C., DC · +40 more sites
RecruitingPhase 3NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Sponsor: Novartis Pharmaceuticals
Washington D.C., DC · +43 more sites
RecruitingPhase 1NCT07224373
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Sponsor: AstraZeneca
Washington D.C., DC · +8 more sites
RecruitingPhase 1NCT06665165
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
Sponsor: Amylyx Pharmaceuticals Inc.
Washington D.C., DC · +9 more sites
Not yet recruitingEarly Phase 1NCT07643974
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD
Sponsor: Medstar Health Research Institute
Washington D.C., DC · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.